Recent articles
Why DBV Technologies Stock Popped Again Today
The French biotech kept its upward momentum going with news of nearly $200 million in fresh funding.
Why StoneCo Sank Like a Stone Today
Another analyst trims her price target on the fintech's stock.
Why Plug Power Stock Weakened on Thursday
The company is about to launch a new financing initiative.
Why Novavax Stock Plummeted on Thursday
There was some bad news on the regulatory front for the vaccine specialist.
2 Stocks That Cut You a Check Each Month
This pair of REITs will line your pockets every few weeks.
Why Curaleaf Stock Got Crushed by the Market Today
An article in a pot publication shines a light on yet another big challenge for the pot industry.
Why DBV Technologies Was a Big Winner on Wednesday
Its peanut allergy patch tests quite well in very young patients.
Why Royal Caribbean and Norwegian Stocks Were Under the Waterline Today
Two analysts lay out uncomfortable scenarios for the two cruise line giants.
Why Investors Slammed the Brakes on Avis Stock Today
In anticipation of falling car rental prices, an analyst trimmed his price target on Avis shares.
Why BioCryst Pharmaceuticals Topped the Market Today
The company receives some good news from a top regulator.
Why Beyond Meat Stock Got Beat by the Market Today
An analyst remains unimpressed by the company's latest retail product launch.
Why Hippo Holdings Stock Stumbled Today
The company's founder and CEO transitions to a new role.
Why Aurora Cannabis Was a Hot Stock Today
An analyst upgrades his recommendation on the Canadian pot purveyor.
Why Peloton Stock Slipped Today
A change in top management isn't sitting particularly well with investors.
Why Cryptocurrency Stocks Shot Higher Today
Monday was a good day for coins and tokens generally, and the performance of affiliated assets reflected this.
Why Sotera Health Stock Crushed the Market Today
The company is about to become a component of an important equity index.
Why Novavax Stock Dipped, Then Soared, on Monday
The good news from a set of FDA briefing documents ultimately outweighed the bad news.
Should You Follow This Billionaire and Sell Disney Stock?
Activist investor Dan Loeb's firm has fully sold out of its position in the entertainment giant.
Why Iovance Stock Leaped 17% Higher Today
Several insiders have been purchasing the company's common shares lately.
Why Amarin Stock Blasted Higher on Friday
An activist investor is getting more active with the company.